Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study

D. D'Amico, A. Solari, S. Usai, P. Santoro, P. Bernardoni, F. Frediani, R. De Marco, N. Massetto, G. Bussone

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Improved health-related quality of life (HRQOL) and reduced activity limitations are prime objectives of migraine therapy, but no data on the effect of preventive treatments on these outcomes are available. We monitored changes in HRQOL using the Short Form 36 (SF-36) and headache-related activity limitations using the Migraine Disability Assessment Score (MIDAS) in 141 consecutive migraine without aura patients on prophylaxis. A total of 102 patients completed the 3-month study. Mean (SD) number of headache days/month dropped from 8.0 (3.7) to 5.0 (2.3) (P <0.001). Mean monthly consumption of acute drugs reduced from 7.4 (3.5) to 4.4 (3.1) (P <0.001). MIDAS total score reduced (improved) significantly. All SF-36 scale scores increased (improved), most significantly. This first study to assess prospectively the impact of prophylaxis on HRQOL and daily activities in a large series indicates that migraine prophylaxis has the potential to reduce the global burden of migraine on individuals and society.

Original languageEnglish
Pages (from-to)691-696
Number of pages6
JournalCephalalgia
Volume26
Issue number6
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Migraine Disorders
Multicenter Studies
Longitudinal Studies
Quality of Life
Headache
Migraine without Aura
Pharmaceutical Preparations
Therapeutics

Keywords

  • Activity limitations
  • Health-related quality of life (HRQoL)
  • Migraine
  • Migraine disability assessment score (MIDAS)
  • Prophylaxis
  • Short form 36 (SF-36)

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. / D'Amico, D.; Solari, A.; Usai, S.; Santoro, P.; Bernardoni, P.; Frediani, F.; De Marco, R.; Massetto, N.; Bussone, G.

In: Cephalalgia, Vol. 26, No. 6, 06.2006, p. 691-696.

Research output: Contribution to journalArticle

D'Amico, D. ; Solari, A. ; Usai, S. ; Santoro, P. ; Bernardoni, P. ; Frediani, F. ; De Marco, R. ; Massetto, N. ; Bussone, G. / Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. In: Cephalalgia. 2006 ; Vol. 26, No. 6. pp. 691-696.
@article{231fb5f0c55a488fa9a48ba9652f6a74,
title = "Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study",
abstract = "Improved health-related quality of life (HRQOL) and reduced activity limitations are prime objectives of migraine therapy, but no data on the effect of preventive treatments on these outcomes are available. We monitored changes in HRQOL using the Short Form 36 (SF-36) and headache-related activity limitations using the Migraine Disability Assessment Score (MIDAS) in 141 consecutive migraine without aura patients on prophylaxis. A total of 102 patients completed the 3-month study. Mean (SD) number of headache days/month dropped from 8.0 (3.7) to 5.0 (2.3) (P <0.001). Mean monthly consumption of acute drugs reduced from 7.4 (3.5) to 4.4 (3.1) (P <0.001). MIDAS total score reduced (improved) significantly. All SF-36 scale scores increased (improved), most significantly. This first study to assess prospectively the impact of prophylaxis on HRQOL and daily activities in a large series indicates that migraine prophylaxis has the potential to reduce the global burden of migraine on individuals and society.",
keywords = "Activity limitations, Health-related quality of life (HRQoL), Migraine, Migraine disability assessment score (MIDAS), Prophylaxis, Short form 36 (SF-36)",
author = "D. D'Amico and A. Solari and S. Usai and P. Santoro and P. Bernardoni and F. Frediani and {De Marco}, R. and N. Massetto and G. Bussone",
year = "2006",
month = "6",
doi = "10.1111/j.1468-2982.2005.01094.x",
language = "English",
volume = "26",
pages = "691--696",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study

AU - D'Amico, D.

AU - Solari, A.

AU - Usai, S.

AU - Santoro, P.

AU - Bernardoni, P.

AU - Frediani, F.

AU - De Marco, R.

AU - Massetto, N.

AU - Bussone, G.

PY - 2006/6

Y1 - 2006/6

N2 - Improved health-related quality of life (HRQOL) and reduced activity limitations are prime objectives of migraine therapy, but no data on the effect of preventive treatments on these outcomes are available. We monitored changes in HRQOL using the Short Form 36 (SF-36) and headache-related activity limitations using the Migraine Disability Assessment Score (MIDAS) in 141 consecutive migraine without aura patients on prophylaxis. A total of 102 patients completed the 3-month study. Mean (SD) number of headache days/month dropped from 8.0 (3.7) to 5.0 (2.3) (P <0.001). Mean monthly consumption of acute drugs reduced from 7.4 (3.5) to 4.4 (3.1) (P <0.001). MIDAS total score reduced (improved) significantly. All SF-36 scale scores increased (improved), most significantly. This first study to assess prospectively the impact of prophylaxis on HRQOL and daily activities in a large series indicates that migraine prophylaxis has the potential to reduce the global burden of migraine on individuals and society.

AB - Improved health-related quality of life (HRQOL) and reduced activity limitations are prime objectives of migraine therapy, but no data on the effect of preventive treatments on these outcomes are available. We monitored changes in HRQOL using the Short Form 36 (SF-36) and headache-related activity limitations using the Migraine Disability Assessment Score (MIDAS) in 141 consecutive migraine without aura patients on prophylaxis. A total of 102 patients completed the 3-month study. Mean (SD) number of headache days/month dropped from 8.0 (3.7) to 5.0 (2.3) (P <0.001). Mean monthly consumption of acute drugs reduced from 7.4 (3.5) to 4.4 (3.1) (P <0.001). MIDAS total score reduced (improved) significantly. All SF-36 scale scores increased (improved), most significantly. This first study to assess prospectively the impact of prophylaxis on HRQOL and daily activities in a large series indicates that migraine prophylaxis has the potential to reduce the global burden of migraine on individuals and society.

KW - Activity limitations

KW - Health-related quality of life (HRQoL)

KW - Migraine

KW - Migraine disability assessment score (MIDAS)

KW - Prophylaxis

KW - Short form 36 (SF-36)

UR - http://www.scopus.com/inward/record.url?scp=33745187307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745187307&partnerID=8YFLogxK

U2 - 10.1111/j.1468-2982.2005.01094.x

DO - 10.1111/j.1468-2982.2005.01094.x

M3 - Article

C2 - 16686908

AN - SCOPUS:33745187307

VL - 26

SP - 691

EP - 696

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 6

ER -